首页> 美国政府科技报告 >Characterizing and Communicating Uncertainty in the Assessment of Benefits and Risksof Pharmaceutical Products. Workshop Summary. Held in White Oak, Maryland on February 12, 2014 and May 12, 2014.
【24h】

Characterizing and Communicating Uncertainty in the Assessment of Benefits and Risksof Pharmaceutical Products. Workshop Summary. Held in White Oak, Maryland on February 12, 2014 and May 12, 2014.

机译:在药品利益和风险评估中表征和传播不确定性。研讨会摘要。 2014年2月12日和2014年5月12日在马里兰州的白橡树举行。

获取原文

摘要

On February 12 and May 12, 2014, the Institute of Medicine’s (IOM’s) Forum on Drug Discovery, Development, and Translation (the Forum) held public workshops at FDA Headquarters in White Oak, Maryland, to advance the development of more systematic and structured approaches to characterize and communicate the sources of uncertainty in the assessment of benefits and risks, and to consider their implications for pharmaceutical regulatory decisions. Workshop presentations and discussions on February 12 were convened to explore the science of identifying and characterizing uncertainty in scientific evidence and approaches to translate uncertainties into decisions that reflect the values of stakeholders. The May 12 workshop presentations and discussions explored tools and approaches to communicating about scientific uncertainties to a range of stakeholders in the drug development process.

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号